nplate® 250 ug polvo para solucion inyectable
tecnofarma s.a. - droguerÍa - romiplostim - polvo para solucion inyectable - 250ug - por vial - - romiplostim
nplate
amgen europe b.v. - romiplostim - púrpura, trombocitopénica, idiopática - antihemorrágicos - adults:nplate is indicated for the treatment of primary immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. corticosteroides, inmunoglobulinas). paediatrics:nplate is indicated for the treatment of chronic primary immune thrombocytopenia (itp) in paediatric patients one year of age and older who are refractory to other treatments (e. corticosteroides, inmunoglobulinas).
nplate 250ug polvo para solución inyectable
amgen inc [us] united states - romiplostim 375 ug - polvo para soluciÓn inyectable - cada vial de 250 ug contiene: romiplostim 375.0 ug
nplate
monte verde s.a. - romiplostim - polvo p/sol.inyec. - romiplostim 250 mcg / 0.5 ml